Not logged in Share Save
Share Save
Utilizing graph machine learning within drug discovery and development Gaudelet, Thomas; Day, Ben; Jamasb, Arian R.; Soman, Jyothish; Regep, Cristian; Liu, Gertrude; Hayter, Jeremy B. R.; Vickers, Richard; Roberts, Charles; Tang, Jian; Roblin, David; Blundell, Tom L.; Bronstein, Michael M.; Taylor-King, Jake P. Share Save
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib The TRAC Randomized Clinical Trial Danilenko, Marina; Stamp, Elaine; Stocken, Deborah D.; Husain, Akhtar; Zangarini, Monique; Cranston, Amy; Stones, Robert; Sinclair, Naomi; Hodgson, Kirsty; Bowett, Susan A.; Roblin, David; Traversa, Silvio; Plummer, Ruth; Veal, Gareth; Langtry, James A. A.; Ashworth, Alan; Burn, John; Rajan, Neil Share Save
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study Vickers, Richard J.; Tillotson, Glenn S.; Nathan, Richard; Hazan, Sabine; Pullman, John; Lucasti, Christopher; Deck, Kenneth; Yacyshyn, Bruce; Maliakkal, Benedict; Pesant, Yves; Tejura, Bina; Roblin, David; Gerding, Dale N.; Wilcox, Mark H. Share Save
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis Roblin, David; Yosipovitch, Gil; Boyce, Brent; Robinson, John; Sandy, James; Mainero, Valentina; Wickramasinghe, Ro; Anand, Uma; Anand, Praveen Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}